News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
493,839 Results
Type
Article (8813)
Company Profile (141)
Press Release (484788)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (169357)
Career Advice (314)
Deals (26130)
Drug Delivery (9)
Drug Development (54340)
Employer Resources (14)
FDA (10072)
Job Trends (8770)
News (242604)
Policy (18308)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (562)
Accelerated approval (24)
ADA (25)
Adcomms (1)
Allergies (97)
Alliances (33749)
ALS (105)
Alzheimer's disease (982)
Antibody-drug conjugate (ADC) (268)
Approvals (10708)
Artificial intelligence (322)
ASCO (163)
Autoimmune disease (210)
Automation (29)
Bankruptcy (272)
Best Places to Work (7152)
BIO (37)
BIOSECURE Act (1)
Biosimilars (141)
BioSpace Insights (18)
Biotechnology (89)
Bladder cancer (138)
Brain cancer (30)
Breast cancer (511)
Cancer (3665)
Cardiovascular disease (218)
Career advice (254)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (37)
Clinical research (49167)
Collaboration (1282)
Commercialization (3)
Compensation (1442)
Complete response letters (35)
COVID-19 (784)
CRISPR (66)
C-suite (777)
Cystic fibrosis (97)
Data (5794)
Denatured (4)
Depression (103)
Dermatology (61)
Diabetes (361)
Diagnostics (4254)
Digital health (37)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (161)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (165)
Earnings (74428)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (89122)
Executive appointments (734)
FDA (12762)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (951)
Gene editing (129)
Generative AI (9)
Gene therapy (357)
GLP-1 (297)
Government (996)
Grass and pollen (2)
Guidances (283)
Healthcare (9670)
Hematology (98)
HIV (53)
Huntington's disease (23)
IgA nephropathy (71)
Immunology and inflammation (104)
Immuno-oncology (56)
Indications (159)
Infectious disease (973)
Inflammatory bowel disease (127)
Inflation Reduction Act (5)
Influenza (85)
Intellectual property (252)
Interviews (45)
IPO (12546)
IRA (2)
Job creations (1993)
Job search strategy (242)
JPM (2)
Kidney cancer (16)
Layoffs (67)
Legal (5249)
Licensing (7)
Liver cancer (45)
Longevity (15)
Lung cancer (509)
Lymphoma (252)
Machine learning (27)
Management (3)
Manufacturing (540)
Marketing (8)
MASH (118)
Medical device (8888)
Medtech (9031)
Mergers & acquisitions (14631)
Metabolic disorders (731)
mRNA (54)
Multiple sclerosis (114)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (38)
Neuroscience (1859)
NextGen: Class of 2026 (3254)
Non-profit (918)
Now hiring (3)
Obesity (231)
Opinion (13)
Ovarian cancer (161)
Pain (178)
Pancreatic cancer (197)
Parkinson's disease (210)
Partnered (11)
Patents (470)
Patient recruitment (527)
Peanut (31)
People (41992)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15843)
Phase 2 (22046)
Phase 3 (14840)
Pipeline (7285)
Policy (19)
Postmarket research (1614)
Preclinical (6677)
Press Release (34)
Prostate cancer (193)
Psychedelics (8)
Radiopharmaceuticals (191)
Rare diseases (598)
Real estate (3084)
Recruiting (6)
Regulatory (15208)
Reports (18)
Research institute (611)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (49)
Schizophrenia (99)
Series A (163)
Series B (134)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2079)
Stomach cancer (3)
Supply chain (50)
Tariffs (1)
The Weekly (1)
Vaccines (323)
Venture capital (18)
Weight loss (74)
Women's health (79)
Date
Today (99)
Last 7 days (559)
Last 30 days (1622)
Last 365 days (19684)
2026 (12136)
2025 (19748)
2024 (23572)
2023 (27223)
2022 (35317)
2021 (37905)
2020 (34213)
2019 (23995)
2018 (18063)
2017 (19300)
2016 (18429)
2015 (24894)
2014 (22122)
2013 (18453)
2012 (20480)
2011 (20725)
2010 (20531)
Location
Africa (238)
Alabama (73)
Alaska (3)
Arizona (301)
Arkansas (11)
Asia (19009)
Australia (2265)
California (12020)
Canada (3158)
China (554)
Colorado (482)
Connecticut (405)
Delaware (215)
Europe (27601)
Florida (1778)
Georgia (373)
Hawaii (3)
Idaho (46)
Illinois (711)
India (73)
Indiana (321)
Iowa (14)
Japan (403)
Kansas (101)
Kentucky (32)
Louisiana (26)
Maine (26)
Maryland (1196)
Massachusetts (7890)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (61)
New Jersey (2642)
New Mexico (12)
New York (2842)
North Carolina (1283)
North Dakota (4)
Northern California (6012)
Ohio (281)
Oklahoma (14)
Oregon (16)
Pennsylvania (2255)
Puerto Rico (22)
Rhode Island (30)
South America (421)
South Carolina (78)
South Dakota (1)
Southern California (4966)
Tennessee (119)
Texas (1909)
United States (38976)
Utah (360)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (933)
West Virginia (1)
Wisconsin (73)
493,839 Results for "amber ophthalmics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
March 2, 2026
·
6 min read
Press Releases
Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio
June 16, 2026
·
2 min read
Press Releases
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
April 9, 2026
·
3 min read
Press Releases
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
July 26, 2026
·
10 min read
Press Releases
UPSHER-SMITH LAUNCHES GENERIC VERSION OF RESTASIS® (CYCLOSPORINE OPHTHALMIC EMULSION 0.05%)
May 20, 2026
·
2 min read
Press Releases
Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease
June 30, 2026
·
8 min read
Press Releases
Omega Ophthalmics LLC Raises $7 Million in a Series A Financing and Schedules FDA Pre-Submission Meeting to Advance Gemini Refractive Capsule Toward U.S. Approval
August 11, 2026
·
3 min read
Press Releases
Hexiris Ophthalmics Marks Scientific Milestones, Launches Digital Presence, and Announces Hands-On Dry Lab at COS Annual Meeting, Montreal
June 8, 2026
·
5 min read
Press Releases
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
·
1 min read
Press Releases
NAMSA and Lexitas Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development
April 30, 2026
·
4 min read
1 of 49,384
Next
